Cardiovascular disease complicating pregnancy is rising in prevalence secondary to advanced maternal age, cardiovascular risk factors, and the successful management of congenital heart disease conditions. The physiological changes of pregnancy may alter drug properties affecting both mother and fetus. Familiarity with both physiological and pharmacological attributes is key for the successful management of pregnant women with cardiac disease. This review summarizes the published data, available guidelines, and recommendations for use of cardiovascular medications during pregnancy. Care of the pregnant woman with cardiovascular disease requires a multidisciplinary team approach with members from cardiology, maternal fetal medicine, anesthesia, and nursing.
Volume 73, Issue 4, February 2019 DOI: 10.1016/j.jacc.2018.10.075
Thursday, February 7, 2019
Subscribe to:
Posts (Atom)
-
I will write more about this in the next blog, but the concept of driving pressure ( Pdr = Vt/Crs- Vt; tidal volume, Crs; compliance respir...
-
CV Medications in Pregnancy Table for Quick Review, I posted this article earlier in the year but not the Central Illustration Cardiova... -
The following are key points to remember from this Expert Consensus Document on the Fourth Universal Definition of Myocardial Infarction (M...